Clinical Trial Update: A Study to Compare the Bioavailability Intranasal Administration of 200 and 400 µg or 400 µg Alone of OPTINOSE™ FLUTICASONE With 440 µg of Flovent® HFA (Fluticasone Propionate) Inhalation Aerosol (Part 2) [Phase 1]

View source ↗

Summary

Phase 1 study assessing relative bioavailability of intranasal OPTINOSE Fluticasone compared with Flovent HFA (fluticasone propionate) inhalation in mild to mod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Flovent HFA (fluticasone propionate)
• OPTINOSE Fluticasone (fluticasone propionate)

Snippet

Sponsor: Optinose US Inc. | Conditions: Mild to Moderate Asthma | Phase 1 | Status: COMPLETED